Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia
Martin Kaiser(Royal Marsden NHS Foundation Trust), Claudia D. Baldus(University Hospital Schleswig-Holstein)
Cited by 74
Related Papers
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
|Journal of Clinical Oncology|2015|564
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1
|Blood|2022|100
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
|Journal of Hematology & Oncology|2022|58
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence
|npj Digital Medicine|2024|58